{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:53:24Z","timestamp":1786737204802,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol India"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/0028-3886.284385","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T03:56:51Z","timestamp":1589515011000},"page":"454","source":"Crossref","is-referenced-by-count":8,"title":["Autologous Stem Cell Transplant in Adult Multiple Sclerosis Patients: A Study from North India"],"prefix":"10.4103","volume":"68","author":[{"given":"Aniruddha","family":"Dayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SantoshR","family":"Kurmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0028-3886.284385-1","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(16)31320-4","article-title":"Progressive multiple sclerosis: Prospects for disease therapy, repair, and restoration of function","author":"Ontaneda","year":"2017","journal-title":"Lancet"},{"key":"key-10.4103\/0028-3886.284385-2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2004.04.020","article-title":"Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: Rationale and clinical experience","author":"Fassas","year":"2004","journal-title":"J Neurol Sci"},{"key":"key-10.4103\/0028-3886.284385-3","first-page":"1","article-title":"Multiple sclerosis","author":"Singhal","year":"1999","journal-title":"Neurol India","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3886","issn-type":"print"},{"key":"key-10.4103\/0028-3886.284385-4","first-page":"459","article-title":"Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis","author":"Pandit","year":"2015","journal-title":"Ann Indian Acad Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0972-2327","issn-type":"print"},{"key":"key-10.4103\/0028-3886.284385-5","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1182\/bloodadvances.2017010041","article-title":"Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases","author":"Snowden","year":"2017","journal-title":"Blood Adv"},{"key":"key-10.4103\/0028-3886.284385-6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/jamaneurol.2016.5867","article-title":"Long-term outcomes after autologous hematopoietic stem cell transplantation for Multiple Sclerosis","author":"Muraro","year":"2017","journal-title":"JAMA Neurol"},{"key":"key-10.4103\/0028-3886.284385-7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0140-6736(16)30169-6","article-title":"Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: A multicentre single-group phase 2 trial","author":"Atkins","year":"2016","journal-title":"Lancet"},{"key":"key-10.4103\/0028-3886.284385-8","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00277-015-2337-8","article-title":"Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: Physician's and patient's perspectives","author":"Shevchenko","year":"2015","journal-title":"Ann Hematol"},{"key":"key-10.4103\/0028-3886.284385-9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/WNL.0000000000003660","article-title":"High-dose immunosuppressive therapy and autologous HCT fo relapsing-remitting MS","author":"Nash","year":"2017","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.284385-10","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1177\/1352458514564484","article-title":"Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study","author":"Curr\u00f2","year":"2015","journal-title":"Mult Scler"}],"container-title":["Neurology India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:51:24Z","timestamp":1786733484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.284385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["284385"],"URL":"https:\/\/doi.org\/10.4103\/0028-3886.284385","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}